Immune Pharmaceuticals Inc.

Jul 09, 2018

WuXi Biologics and Immune Pharmaceuticals Announce Late-Phase Development and Manufacturing Partnership for a First-In-Class Monoclonal Antibody

Dec 19, 2017

What's Happening With These Drug Makers Stocks? -- Immune Pharmaceuticals, Zogenix, Shire, and Merck

Sep 22, 2017

Drug Makers Stocks on Investors' Radar -- Alliqua BioMedical, Immune Pharma, Eli Lilly, and Merck

Jun 29, 2017

Immune Pharmaceuticals' Oncology Subsidiary, Cytovia Inc. Provides Update to Proposed Pint Pharma Transaction: Substantial Agreement Reached on Material Terms of the Licensing and Commercialization of Ceplene® in Latin America

Jun 20, 2017

Immune Pharmaceuticals announces initiation of enrollment in clinical trial with Ceplene®/ low-dose IL-2 in Chronic Myelomonocytic Leukemia (CMML)

Jun 19, 2017

Immune Receives NASDAQ Compliance Letter

Jun 15, 2017

Immune Pharmaceuticals Signs Agreement to Regain Worldwide Rights for Ceplene

Jun 02, 2017

Research Reports Initiation on Drug Makers Stocks -- Immune Pharma, Impax Labs, Heron Therapeutics, and Alimera Sciences

May 26, 2017

Immune Receives Nasdaq Letters